Navigation Links
Abbott and Enanta Present Positive Initial Results from Phase 2 Study of ABT-450/r for Treatment of Hepatitis C
Date:11/1/2010

50 was discovered as part of an alliance between Abbott and Enanta and is being developed with low-dose ritonavir, which enhances the pharmacokinetic properties of ABT-450, allowing for once-daily dosing. This Phase 2 study also evaluated ABT-333 and ABT-072, two of Abbott's internally discovered compounds that are part of the company's ongoing non-nucleoside polymerase inhibitor development program. The study findings for these two compounds have been submitted for presentation at a future scientific meeting.

About the Hepatitis C VirusHepatitis C is a liver disease affecting more than 180 million people worldwide.  The virus is primarily spread through direct contact with the blood of an infected person.  HCV increases a person's risk of developing chronic liver disease, cirrhosis, liver cancer and death.

Liver disease associated with HCV infection is growing rapidly, and current therapies only cure about half of patients with the genotype 1 form of the virus. Specifically targeted antiviral therapies for HCV, such as protease inhibitors and non-nucleoside polymerase inhibitors, may have the potential to increase the proportion of patients in whom the virus can be eradicated.

About Ritonavir The use of NORVIR® (ritonavir) with ABT-450 for the treatment of HCV is investigational.

NORVIR is in a class of medicines called the HIV protease (PRO-tee-ase) inhibitors. NORVIR is used in combination with other anti-HIV medicines to treat people with human immunodeficiency virus (HIV) infection. NORVIR is for adults and for children age greater than 1 month and older.

NORVIR does not cure HIV infection or AIDS and does not reduce the risk of passing HIV to others. People taking NORVIR may still get opportunistic infections or other conditions that happen with HIV infection. Some of these conditions are pneumonia, herpes virus infections, and Mycobacterium avium complex (MAC) infections.

People should
'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Abbott Again Recognized for Environmental Initiatives in Illinois
2. Abbott Statement: Abbott Provides Support for Cholera Relief Efforts in Haiti
3. Abbott to Voluntarily Withdraw Meridia® (Sibutramine) in the U.S.
4. Abbott Laboratories Agrees to Withdraw Its Obesity Drug Meridia
5. Abbott Named One of the Top Employers in the Biotech and Pharmaceutical Industry by Science Magazine
6. Abbott Receives FDA Market Clearance for Next-Generation Contact Lens Disinfecting Solution
7. Abbotts XIENCE V® Shows Continued Strong Performance in Key Safety and Efficacy Measures at Two Years in Investigator-Initiated COMPARE Trial
8. Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S.
9. Abbotts Fully Bioresorbable Vascular Scaffold Technology Continues to Demonstrate Strong Clinical Results
10. The Deal Names Abbott Top Dealmaker for Third Consecutive Year
11. Abbott Declares 347th Consecutive Quarterly Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 2014   Ventana Medical Systems, Inc.  (Ventana), a ... entered into an agreement with Merck KGaA, Darmstadt, ... in the United States and ... KGaA,s biopharmaceutical division on the development and commercialization of ... Ventana,s proprietary diagnostic assays. In alignment with Merck KGaA,s ...
(Date:1/15/2014)... Sono-Tek Corporation (OTC BB: SOTK) today announced sales of  ... to sales of $2,202,000 for the prior year period, an ... also shown growth over the preceding quarter,s sales, continuing a ... year. Markets that experienced sales increases over the prior year ...
(Date:1/15/2014)... Foundation today announced it has established a relief fund ... weather that has gripped much of the nation. AARP and ... to support these emergency relief efforts AARP and AARP Foundation ... up to $500,000 in aid. The matching program will be ...
Breaking Medicine Technology:Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3
... Fuisz ( www.fuisz.com ) today announced the issuance ... Stage Door Access to On-Line Vendor Information"). ... patent covers a system that allows a customer or ... product supplier database through the on-line vendor,s system to ...
... help simplify the OR, Ethicon Endo-Surgery, Inc. (EES) today announces ... ever Advanced Energy Generator made to power both ultrasonic and ... use in the operating room. "The operating ... Judith Butt, Theatre Nurse, Prince Charles Hospital, Wales, UK ...
Cached Medicine Technology:Ethicon Endo-Surgery Introduces Innovative New Generator to Help Simplify Use of Advanced Energy Technology in the OR 2
(Date:7/12/2014)... Wright & Schulte LLC, an experienced law firm ... Lawsuits (case #59776/2014), announces they have launched a new ... the popular hair dye, Just For Men, has caused some ... and other areas. In addition to detailing symptoms that are ... the advertisements being run by Wright & Schulte LLC will ...
(Date:7/12/2014)... Beach, FL (PRWEB) July 12, 2014 ... of high-quality peptides that are used solely in scientific ... honor two successful years in business, Maxim Peptide, which ... has just launched a new and updated website that ... research blog section has been updated with fascinating articles ...
(Date:7/11/2014)... Recently, MagicQuinceaneraDresses.com, the popular online supplier of ... 2014 Quinceanera dresses . The company’s new items ... fashionable without paying a large amount of money. They ... off. , The company’s online shop has become a ... occasion outfits. In addition to exquisite Quinceanera dresses, it ...
(Date:7/11/2014)... 12, 2014 According to new ... market is expected to register a CAGR of ... Browse 71 market data tables and 76 figures ... "C4ISR Market"., http://www.marketsandmarkets.com/Market-Reports/c4isr-market-1315.html , Early buyers ... http://www.marketsandmarkets.com/requestCustomization.asp?id=1315 , The report provides market analysis ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 Butler Mobility has ... Inclined Platform Lifts . Previously the two standard ... five new beautiful earth tone colors as standard colors at ... well in the home but will enhance the beauty of ... for any home color scheme or individual décor. , The ...
Breaking Medicine News(10 mins):Health News:Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns 2Health News:Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns 3Health News:Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns 4Health News:Maxim Peptide Celebrates Second Anniversary Online with an Updated Website and Special Deals Section 2Health News:Cheap Quinceanera Dresses Now Available At MagicQuinceaneraDresses.com 2Health News:C4ISR Market Estimated to Reach $93.04 Billion by 2019 - New Report by MarketsandMarkets 2Health News:C4ISR Market Estimated to Reach $93.04 Billion by 2019 - New Report by MarketsandMarkets 3Health News:C4ISR Market Estimated to Reach $93.04 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Butler Mobility Products Announces Five New Standard Colors for Their Inclined Platform Lifts 2
... commonly prescribed cholesterol-lowering drug ezetimibe (Zetia) is so potent. ... University School of Medicine, is reported online today by ... the July 2 print issue. ,It had ... cells in the intestine from absorbing cholesterol. The new ...
... Louis researchers have identified common DNA variations that ... of the eight genetic alterations the scientists identified ... vaccination. A few, however, reduced fever risk. ... same genetic variations linked to fever following smallpox ...
... to scientist at annual conference of the European Society ... abnormal can undergo chromosomal modifications. , ... Maternity Hospital, Tel Aviv Sourasky Medical Centre, Tel Aviv, ... meant that the results of preimplantation genetic screening (PGS) ...
... For many decades, medical research studies focused primarily on ... applied to women. But we now know that the ... women are more than skin deep. Beginning in 1990, ... based advocacy organization, conveyed to a national audience the ...
... and their friends filled the area in and around the ... 14th annual Komen Puget Sound Race for the Cure . ... cancer, while many others were running to honor family members ... in the pink T-shirts and sporting the medallions awarded by ...
... much as $2.7 billion a year, according to the Access ... of Crohn's disease and ulcerative colitis. Crohn's disease is a ... ulcerations (breaks in the lining) of the small and large ... mouth to the anus. It is named after the physician ...
Cached Medicine News:Health News:Animal Research Uncovers Another Mechanism of Cholesterol Lowering Drug 2Health News:Genetic Variations Leads to Fever After Smallpox Vaccination 2Health News:Genetic Variations Leads to Fever After Smallpox Vaccination 3Health News:Preimplanted Genetic Screening Should Be Interpreted With Caution 2Health News:Rare Womens Lung Disease May Yield Insights Into Common Diseases 2Health News:Annual Cancer Run Draws Huge Response in US 2Health News:Inflamed Intestines Cost Australians Heavily 2
The FastPack system is a state of the art, lab quality immunoassay system designed for rapid results. The FastPack system delivers lab-quality sensitivity at a fraction of the cost of laboratory....
... When you need quick, accurate, convenient, and ... compact VITROS DT60 II Chemistry System. This ... and back-up laboratory testing requirements. And it ... -- better patient outcomes, reduced overall costs, ...
... In an effort to improve on ... hormones, toxicology, abused drugs, and immunosuppressants ... 1991 which incorporates random access capabilities. ... has undergone several important changes in ...
AxSYM Plus provides cutting-edge ergonomics and smart new features that mean increased ease-of-use and enhanced reliability. Also, advanced software means less operator intervention and high-integrit...
Medicine Products: